Bessemer Venture Partners

Bessemer Venture Partners is a prominent venture capital firm, founded in 1911 and based in Redwood City, California. With approximately $4 billion in assets under management, the firm invests globally in startups across various sectors, including consumer, enterprise, healthcare, information technology, and deep tech, from seed stage to growth. Bessemer's partners are dedicated to supporting founders by providing guidance and resources throughout the company's lifecycle. The firm has a notable track record of backing early-stage investments in companies such as Pinterest, Skype, and Twitch, and has played a significant role in the development of 117 IPOs, including notable names like Twilio and LinkedIn. With funds targeting a range of sectors, Bessemer Venture Partners exemplifies a commitment to fostering innovation and building enduring businesses.

Anurag Begwani

Investor

Kent Bennett

Partner

Tom Berger

Partner

Charles Birnbaum

Partner

Sam Bondy

Investor

William Burgin

Partner

Sara Byrne

Partner and CFO

Aparna Chaganty

Investor

Morgan Cheatham

Vice President

Justina Chung

Vice President

David Cowan

Partner

Brian Cramer

Operating Partner

Mary D'Onofrio

Partner

Byron Deeter

Partner

Sameer Dholakia

Partner

John Drake

Investor

Mike Droesch

Partner

Jeff Epstein

Operating Partner

Adam Ferrara

Partner

Libbie Frost

Investor

Andrew Geisse

Operating Partner

Talia Goldberg

Partner

Bob Goodman

Partner

Alexa Grabelle

Investor

Sandy Grippo

COO and Partner

Sofia Guerra

Vice President, Cambridge office

Vishal Gupta

Managing Director, Partner

Tess Hatch

Partner

Andrew Hedin

Partner

Sachin Jain

Investor

Nithin Kaimal

COO

Eric Kaplan

Investor

Stephen Kraus

Partner

Ethan Kurzweil

Partner

Lindsey Li

Vice President

Grace Ma

Investor

Maha Malik

Investor

Bhavik Nagda

Investor

Aditya Nidmarti

Investor

Bob O'Neil

Venture Partner

Darsh Patel

Investor

Anant Vidur Puri

Partner

Caty Rea

Vice President

Raj Sabhlok

Operating Partner

Jason Scheller

Investor

Yael Schiff

Vice President

Andrew Schmitt

Investor

Madeline Shue

Investor

Scott Smith

Operating Partner

Robert Stavis

Partner

Mayo Stuntz

Operating Partner

Vatsalya Tandon

Investor

Janice Teng

Vice President

Christopher Wan

Vice President

Bryan Wu

Partner

Alex Yuditski

Investor

Moksha .

Investor

Past deals in New England

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Courier

Series B in 2022
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.

Devo

Series F in 2022
Devo, Inc. is a cloud-native platform specializing in centralized log management and security analytics. The company offers a comprehensive enterprise log management solution that enables organizations to collect and analyze machine data from various sources, facilitating insights into applications, infrastructure, and business systems through real-time dashboards and alerts. Devo's product suite includes Devo Data Operations for data collection and management, Devo Service Operations for monitoring complex applications, and Devo Machine Learning Workbench for data science teams. These tools support various use cases, including threat detection, centralized log management, and monitoring in complex environments. Devo serves a diverse range of industries, including financial services, retail, telecommunications, and software as a service providers. Founded in 2011 and originally named Logtrust, the company is headquartered in Cambridge, Massachusetts, with an additional office in Madrid, Spain.

BlockJoy

Seed Round in 2021
BlockJoy is a venture-backed Web3 infrastructure company that enables to run their own blockchain nodes on any infrastructure they prefer.

Devo

Series E in 2021
Devo, Inc. is a cloud-native platform specializing in centralized log management and security analytics. The company offers a comprehensive enterprise log management solution that enables organizations to collect and analyze machine data from various sources, facilitating insights into applications, infrastructure, and business systems through real-time dashboards and alerts. Devo's product suite includes Devo Data Operations for data collection and management, Devo Service Operations for monitoring complex applications, and Devo Machine Learning Workbench for data science teams. These tools support various use cases, including threat detection, centralized log management, and monitoring in complex environments. Devo serves a diverse range of industries, including financial services, retail, telecommunications, and software as a service providers. Founded in 2011 and originally named Logtrust, the company is headquartered in Cambridge, Massachusetts, with an additional office in Madrid, Spain.

Nym

Venture Round in 2021
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

Shift Technology

Series D in 2021
Shift Technology SAS is a Paris-based company that develops a software-as-a-service platform tailored for the insurance industry. Founded in 2013, it leverages artificial intelligence and extensive data analysis to identify patterns and detect fraudulent insurance claims. The company offers two primary solutions: FORCE, designed for fraud detection, and Luke, which automates claims processing for handlers and managers. Shift Technology addresses critical processes throughout the insurance policy lifecycle, enabling insurers to achieve faster and more accurate claims resolutions. With a significant analysis of billions of insurance transactions, the company has received recognition for its innovative contributions to the industry, including an award for market leadership in claims solutions. In addition to its headquarters in Paris, Shift Technology has established offices in major cities worldwide, including Boston, Tokyo, London, and Singapore.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Yotpo

Series F in 2021
Yotpo Ltd. is an eCommerce marketing platform that provides companies with tools to leverage user-generated content for marketing purposes. Founded in 2011 and headquartered in Tel Aviv, with additional offices in New York, Boston, and London, Yotpo helps brands like Patagonia and Gymshark gather customer reviews, photos, and videos, which can enhance marketing, referral, and loyalty programs. The platform integrates various solutions, including customer reviews, loyalty programs, and SMS marketing, to foster direct-to-consumer growth. By acquiring companies like Swell Rewards and SMSBump, Yotpo has expanded its offerings to include loyalty and referral capabilities. The platform is compatible with major eCommerce systems such as Shopify and Magento, allowing businesses to utilize data-driven insights to improve customer experiences and relationships.

FOLX

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

TScan Therapeutics

Series C in 2021
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

Fuze

Venture Round in 2021
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

FOLX

Venture Round in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Friday.app

Seed Round in 2020
Spend more time doing your best work and less time talking about it.

Nym

Series A in 2020
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

Nebulous

Seed Round in 2020
Nebulous, Inc. is a company focused on developing blockchain hardware and software for the decentralized internet. Founded in 2014 and based in Boston, Massachusetts, it operates Sia, a decentralized cloud storage platform that creates a marketplace for data storage by connecting users in need of file storage with hosts offering underutilized hard drive capacity. Utilizing blockchain technology, Sia enhances security and cost-effectiveness, enabling transactions through smart contracts without the need for intermediaries. In addition to Sia, Nebulous offers Skynet, a decentralized content delivery network and file-sharing platform designed for developers, and SiaStream, which provides affordable storage solutions for media files, facilitating quick streaming. Through these initiatives, Nebulous aims to deliver a robust and economical alternative to traditional cloud storage providers.

Devo

Series D in 2020
Devo, Inc. is a cloud-native platform specializing in centralized log management and security analytics. The company offers a comprehensive enterprise log management solution that enables organizations to collect and analyze machine data from various sources, facilitating insights into applications, infrastructure, and business systems through real-time dashboards and alerts. Devo's product suite includes Devo Data Operations for data collection and management, Devo Service Operations for monitoring complex applications, and Devo Machine Learning Workbench for data science teams. These tools support various use cases, including threat detection, centralized log management, and monitoring in complex environments. Devo serves a diverse range of industries, including financial services, retail, telecommunications, and software as a service providers. Founded in 2011 and originally named Logtrust, the company is headquartered in Cambridge, Massachusetts, with an additional office in Madrid, Spain.

Courier

Series A in 2020
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.

Nido Biosciences

Venture Round in 2020
Nido Biosciences, Inc., founded in 2018 and based in Boston, Massachusetts, operates in the healthcare services sector. The company specializes in biotechnology and personal health, aiming to innovate within these fields. Currently in stealth mode, Nido Biosciences is focused on developing solutions that address unmet needs in healthcare and personal health management.

Nym

Venture Round in 2020
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

Yotpo

Series E in 2020
Yotpo Ltd. is an eCommerce marketing platform that provides companies with tools to leverage user-generated content for marketing purposes. Founded in 2011 and headquartered in Tel Aviv, with additional offices in New York, Boston, and London, Yotpo helps brands like Patagonia and Gymshark gather customer reviews, photos, and videos, which can enhance marketing, referral, and loyalty programs. The platform integrates various solutions, including customer reviews, loyalty programs, and SMS marketing, to foster direct-to-consumer growth. By acquiring companies like Swell Rewards and SMSBump, Yotpo has expanded its offerings to include loyalty and referral capabilities. The platform is compatible with major eCommerce systems such as Shopify and Magento, allowing businesses to utilize data-driven insights to improve customer experiences and relationships.

FOLX

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

FOLX

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Fractyl Health

Venture Round in 2020
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Kymera Therapeutics

Series C in 2020
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, established in 2015. It specializes in targeted protein degradation, developing innovative small molecule therapeutics that selectively degrade proteins associated with various diseases by utilizing the body's natural protein degradation mechanisms. The company is advancing several therapeutic programs, including the IRAK4 program aimed at treating immunology-inflammation diseases such as hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis. Additionally, it is developing the IRAKIMiD program for MYD88-mutated diffuse large B cell lymphoma and the STAT3 program for hematologic malignancies and solid tumors, as well as autoimmune diseases. Through its proprietary predictive modeling platform, Kymera Therapeutics seeks to accelerate drug discovery and address previously untreatable conditions.

Toast

Series F in 2020
Toast, Inc. is a Boston-based company that specializes in developing a comprehensive point-of-sale and restaurant management platform tailored for the foodservice and hospitality industries. Founded in 2011, Toast provides cloud-based solutions that include online ordering, delivery tracking, tableside ordering, and labor management, all designed to streamline restaurant operations. The platform serves a diverse range of establishments, including restaurants, cafés, bars, and nightclubs, enabling them to enhance customer experiences and optimize business performance. By offering software subscription services, processing transaction fees, and providing financing through its Toast Capital division, Toast supports over 120,000 restaurant locations across the United States. The company stands out by processing a significant volume of financial transactions on its platform, reinforcing its commitment to delivering a robust and effective technology solution for restaurateurs.

Courier

Venture Round in 2020
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.

TScan Therapeutics

Series B in 2020
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

TScan Therapeutics

Series B in 2019
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

Nebulous

Seed Round in 2019
Nebulous, Inc. is a company focused on developing blockchain hardware and software for the decentralized internet. Founded in 2014 and based in Boston, Massachusetts, it operates Sia, a decentralized cloud storage platform that creates a marketplace for data storage by connecting users in need of file storage with hosts offering underutilized hard drive capacity. Utilizing blockchain technology, Sia enhances security and cost-effectiveness, enabling transactions through smart contracts without the need for intermediaries. In addition to Sia, Nebulous offers Skynet, a decentralized content delivery network and file-sharing platform designed for developers, and SiaStream, which provides affordable storage solutions for media files, facilitating quick streaming. Through these initiatives, Nebulous aims to deliver a robust and economical alternative to traditional cloud storage providers.

Nym

Seed Round in 2019
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

CozyKin

Series A in 2019
CozyKin, Inc. offers nanny services tailored for new or expecting parents, focusing on providing high-quality childcare. Founded in 2016, the company operates from Allston, Massachusetts, with an additional office in New York City. CozyKin employs a unique model by connecting families with Montessori-trained nannies, enabling caregivers to attend to 2-3 infants at a time in the families' homes. This service addresses the challenges faced by millennial families, who often struggle to find suitable childcare due to a shortage of options and a desire for developmentally appropriate care. By leveraging modern technology, CozyKin facilitates a two-sided marketplace that matches families based on location, schedule, and preferences while offering continuous customer support. In 2020, CozyKin was acquired by Higher Ground Education, further strengthening its position in the childcare industry.

Verata Health

Series A in 2019
Verata Health, Inc. specializes in developing artificial intelligence-driven software solutions aimed at streamlining the prior authorization process in healthcare. The company's platform synthesizes clinical documentation and medical necessity rules to provide real-time decision recommendations, effectively reducing the administrative burdens associated with prior authorizations. By serving private practices, pharmacies, and health systems, Verata Health enhances the efficiency of healthcare delivery, ensuring that patients receive timely and appropriate care. Founded in 2017 and headquartered in Bloomington, Minnesota, with additional offices in Minneapolis, Boston, and Orlando, Verata Health was acquired by Olive, Inc. in December 2020.

Toast

Series E in 2019
Toast, Inc. is a Boston-based company that specializes in developing a comprehensive point-of-sale and restaurant management platform tailored for the foodservice and hospitality industries. Founded in 2011, Toast provides cloud-based solutions that include online ordering, delivery tracking, tableside ordering, and labor management, all designed to streamline restaurant operations. The platform serves a diverse range of establishments, including restaurants, cafés, bars, and nightclubs, enabling them to enhance customer experiences and optimize business performance. By offering software subscription services, processing transaction fees, and providing financing through its Toast Capital division, Toast supports over 120,000 restaurant locations across the United States. The company stands out by processing a significant volume of financial transactions on its platform, reinforcing its commitment to delivering a robust and effective technology solution for restaurateurs.

Shift Technology

Series C in 2019
Shift Technology SAS is a Paris-based company that develops a software-as-a-service platform tailored for the insurance industry. Founded in 2013, it leverages artificial intelligence and extensive data analysis to identify patterns and detect fraudulent insurance claims. The company offers two primary solutions: FORCE, designed for fraud detection, and Luke, which automates claims processing for handlers and managers. Shift Technology addresses critical processes throughout the insurance policy lifecycle, enabling insurers to achieve faster and more accurate claims resolutions. With a significant analysis of billions of insurance transactions, the company has received recognition for its innovative contributions to the industry, including an award for market leadership in claims solutions. In addition to its headquarters in Paris, Shift Technology has established offices in major cities worldwide, including Boston, Tokyo, London, and Singapore.

Affirmed Networks

Venture Round in 2019
Affirmed Networks, Inc. specializes in providing mobile content cloud solutions globally, focusing on virtualization and network functions. Founded in 2010 and based in Acton, Massachusetts, the company offers a range of services including the Affirmed Service Automation Platform, which helps mobile operators streamline service introduction and reduce operational costs. Their solutions encompass a cloud-based virtual network for Internet of Things services, critical data communications for telecommunications, and virtualized Evolved Packet Core solutions for live traffic management. Additionally, Affirmed Networks has developed UnityCloud 5G core, a cloud-native platform designed to facilitate the deployment of 5G networks for mobile operators. The company's innovative approach aims to enhance intelligence and efficiency in mobile data networks.

Bevi

Series C in 2019
Bevi is a manufacturer of bottle-less water dispensers designed for offices and commercial spaces. The company's innovative products enable users to create custom beverages while accessing nutritional information and tracking the environmental impact of their choices. By utilizing the municipal water supply, Bevi aims to eliminate waste associated with the production, shipping, and disposal of bottled beverages. The dispensers offer a range of flavors made from real fruit essence, promoting healthier and more sustainable hydration options for employees in various settings.

Kymera Therapeutics

Series B in 2018
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, established in 2015. It specializes in targeted protein degradation, developing innovative small molecule therapeutics that selectively degrade proteins associated with various diseases by utilizing the body's natural protein degradation mechanisms. The company is advancing several therapeutic programs, including the IRAK4 program aimed at treating immunology-inflammation diseases such as hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis. Additionally, it is developing the IRAKIMiD program for MYD88-mutated diffuse large B cell lymphoma and the STAT3 program for hematologic malignancies and solid tumors, as well as autoimmune diseases. Through its proprietary predictive modeling platform, Kymera Therapeutics seeks to accelerate drug discovery and address previously untreatable conditions.

Centivo

Series A in 2018
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

Renoviso

Series B in 2018
Renoviso, Inc., based in North Andover, Massachusetts, specializes in home renovation services, particularly in window and door replacement, as well as hardwood flooring. Established in 2014, the company leverages technology to enhance the renovation experience for homeowners, offering customized online pricing from reputable brands in the home improvement sector. Renoviso manages the entire renovation process, from professional measurement to installation, ensuring transparency and a high level of customer satisfaction. Its innovative approach has garnered positive reviews from homeowners across eastern New England, highlighting Renoviso's commitment to quality and affordability in home renovation projects.

Decibel Therapeutics

Series C in 2018
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing therapies aimed at protecting, repairing, and restoring hearing. The company focuses on a range of hearing disorders, including those related to cancer treatments, cystic fibrosis, noise exposure, age-related and genetic hearing loss, as well as tinnitus. It utilizes advanced techniques such as single-cell genomics, bioinformatics, and precision gene therapy technologies to enhance its understanding of inner ear pathology and to develop effective treatments. Decibel Therapeutics also offers expertise in drug delivery to the inner ear, imaging, and pharmacokinetic modeling, contributing to innovative therapeutic approaches for patients experiencing various forms of hearing loss. Founded in 2013 and based in Boston, Massachusetts, Decibel Therapeutics was previously known as Hearing, Inc. before rebranding in 2014.

Fuze

Series F in 2018
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

CozyKin

Seed Round in 2017
CozyKin, Inc. offers nanny services tailored for new or expecting parents, focusing on providing high-quality childcare. Founded in 2016, the company operates from Allston, Massachusetts, with an additional office in New York City. CozyKin employs a unique model by connecting families with Montessori-trained nannies, enabling caregivers to attend to 2-3 infants at a time in the families' homes. This service addresses the challenges faced by millennial families, who often struggle to find suitable childcare due to a shortage of options and a desire for developmentally appropriate care. By leveraging modern technology, CozyKin facilitates a two-sided marketplace that matches families based on location, schedule, and preferences while offering continuous customer support. In 2020, CozyKin was acquired by Higher Ground Education, further strengthening its position in the childcare industry.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Edmit

Seed Round in 2017
Edmit was founded by innovative university leaders passionate about student success. We believe students should feel empowered in the college admissions and financial aid process, and that colleges should have more effective ways to engage directly with students on pricing in order to effectively bring great students to their institution.

Yotpo

Series D in 2017
Yotpo Ltd. is an eCommerce marketing platform that provides companies with tools to leverage user-generated content for marketing purposes. Founded in 2011 and headquartered in Tel Aviv, with additional offices in New York, Boston, and London, Yotpo helps brands like Patagonia and Gymshark gather customer reviews, photos, and videos, which can enhance marketing, referral, and loyalty programs. The platform integrates various solutions, including customer reviews, loyalty programs, and SMS marketing, to foster direct-to-consumer growth. By acquiring companies like Swell Rewards and SMSBump, Yotpo has expanded its offerings to include loyalty and referral capabilities. The platform is compatible with major eCommerce systems such as Shopify and Magento, allowing businesses to utilize data-driven insights to improve customer experiences and relationships.
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Groups Recover Together

Venture Round in 2017
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

MealPal

Series B in 2017
MealPal, Inc. is a subscription service that provides members with access to a wide range of lunch options for a flat monthly fee. Founded in 2015 and based in Miami, Florida, the company allows users to choose and reserve meals from participating restaurants, food service providers, and chefs in various urban areas including Washington, D.C., San Francisco, New York, Miami, Boston, London, Philadelphia, and Chicago. Members can pre-order meals the night before or on the day they wish to pick up their lunch, thus avoiding long lines during busy lunch hours. MealPal also offers gift options and has facilitated over 10 million lunch reservations, helping restaurants increase their revenue during peak times. The company was previously known as MealPass, Inc. before rebranding in 2016.

Toast

Series C in 2017
Toast, Inc. is a Boston-based company that specializes in developing a comprehensive point-of-sale and restaurant management platform tailored for the foodservice and hospitality industries. Founded in 2011, Toast provides cloud-based solutions that include online ordering, delivery tracking, tableside ordering, and labor management, all designed to streamline restaurant operations. The platform serves a diverse range of establishments, including restaurants, cafés, bars, and nightclubs, enabling them to enhance customer experiences and optimize business performance. By offering software subscription services, processing transaction fees, and providing financing through its Toast Capital division, Toast supports over 120,000 restaurant locations across the United States. The company stands out by processing a significant volume of financial transactions on its platform, reinforcing its commitment to delivering a robust and effective technology solution for restaurateurs.

Toast

Series C in 2017
Toast, Inc. is a Boston-based company that specializes in developing a comprehensive point-of-sale and restaurant management platform tailored for the foodservice and hospitality industries. Founded in 2011, Toast provides cloud-based solutions that include online ordering, delivery tracking, tableside ordering, and labor management, all designed to streamline restaurant operations. The platform serves a diverse range of establishments, including restaurants, cafés, bars, and nightclubs, enabling them to enhance customer experiences and optimize business performance. By offering software subscription services, processing transaction fees, and providing financing through its Toast Capital division, Toast supports over 120,000 restaurant locations across the United States. The company stands out by processing a significant volume of financial transactions on its platform, reinforcing its commitment to delivering a robust and effective technology solution for restaurateurs.

Clear Ballot

Venture Round in 2017
Clear Ballot Group, Inc. develops election software and hardware products. The company offers ClearVote, a vote visualization system for election officials. It also provides modular voting systems, and software tools and hardware. The company serves counties and municipalities in the United States. Clear Ballot Group, Inc. was founded in 2009 and is based in Boston, Massachusetts.

Groups Recover Together

Venture Round in 2017
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Fam

Convertible Note in 2017
Fam's mission is to build products that revolutionize the way teens and millennials communicate. They believe in a calculated combination of live group video and group chat messaging to execute this. It is the world’s first group video chat app for iMessage, with over 7 million users. Their app instantly connects with the family and friends closest to its user through group video calling, right from their iPhone, and Android text message app.

MealPal

Series A in 2017
MealPal, Inc. is a subscription service that provides members with access to a wide range of lunch options for a flat monthly fee. Founded in 2015 and based in Miami, Florida, the company allows users to choose and reserve meals from participating restaurants, food service providers, and chefs in various urban areas including Washington, D.C., San Francisco, New York, Miami, Boston, London, Philadelphia, and Chicago. Members can pre-order meals the night before or on the day they wish to pick up their lunch, thus avoiding long lines during busy lunch hours. MealPal also offers gift options and has facilitated over 10 million lunch reservations, helping restaurants increase their revenue during peak times. The company was previously known as MealPass, Inc. before rebranding in 2016.

Fuze

Series E in 2017
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

Quantopian

Series C in 2016
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

Renoviso

Series A in 2016
Renoviso, Inc., based in North Andover, Massachusetts, specializes in home renovation services, particularly in window and door replacement, as well as hardwood flooring. Established in 2014, the company leverages technology to enhance the renovation experience for homeowners, offering customized online pricing from reputable brands in the home improvement sector. Renoviso manages the entire renovation process, from professional measurement to installation, ensuring transparency and a high level of customer satisfaction. Its innovative approach has garnered positive reviews from homeowners across eastern New England, highlighting Renoviso's commitment to quality and affordability in home renovation projects.

Docent Health

Series A in 2016
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.

Yotpo

Series C in 2016
Yotpo Ltd. is an eCommerce marketing platform that provides companies with tools to leverage user-generated content for marketing purposes. Founded in 2011 and headquartered in Tel Aviv, with additional offices in New York, Boston, and London, Yotpo helps brands like Patagonia and Gymshark gather customer reviews, photos, and videos, which can enhance marketing, referral, and loyalty programs. The platform integrates various solutions, including customer reviews, loyalty programs, and SMS marketing, to foster direct-to-consumer growth. By acquiring companies like Swell Rewards and SMSBump, Yotpo has expanded its offerings to include loyalty and referral capabilities. The platform is compatible with major eCommerce systems such as Shopify and Magento, allowing businesses to utilize data-driven insights to improve customer experiences and relationships.

Alcresta

Series C in 2016
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

Fuze

Series D in 2016
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

SmashFly Technologies

Series B in 2016
SmashFly Technologies’s award-winning Total Recruitment Marketing Platform enables talent acquisition teams to attract, engage, nurture and convert candidates into qualified applicants using a centralized management system that automates and measures recruiting strategies and programs. Customers use SmashFly to unite their previously disconnected recruiting tools into an integrated software platform for Job Distribution, Candidate Relationship Management (CRM), Talent Networks, mobile-responsive and SEO-optimized Career Sites, Employee Referrals, Social Recruiting and Recruiting Analytics. Used to target pre-applicants in the front-end of the talent acquisition process, SmashFly integrates with any applicant tracking system (ATS) to provide unparalleled, real-time analytics on the sources that produce the best hires for the organization.

Docent Health

Seed Round in 2016
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.

Toast

Series B in 2016
Toast, Inc. is a Boston-based company that specializes in developing a comprehensive point-of-sale and restaurant management platform tailored for the foodservice and hospitality industries. Founded in 2011, Toast provides cloud-based solutions that include online ordering, delivery tracking, tableside ordering, and labor management, all designed to streamline restaurant operations. The platform serves a diverse range of establishments, including restaurants, cafés, bars, and nightclubs, enabling them to enhance customer experiences and optimize business performance. By offering software subscription services, processing transaction fees, and providing financing through its Toast Capital division, Toast supports over 120,000 restaurant locations across the United States. The company stands out by processing a significant volume of financial transactions on its platform, reinforcing its commitment to delivering a robust and effective technology solution for restaurateurs.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

CyPhy Works

Series B in 2015
CyPhy Works, now known as Aria Insights, specializes in the development of intelligent aerial robots designed to operate in challenging and hazardous environments. By integrating advanced technology, these robots collect and analyze data, providing actionable insights to decision-makers. This approach not only enhances operational efficiency but also prioritizes safety by minimizing human exposure to risky situations. Through their innovative solutions, Aria Insights aims to transform data collection and analysis in various sectors, ensuring that critical information is delivered effectively and securely.

Apperian

Series C in 2015
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

HelloShopper

Seed Round in 2015
HelloShopper (formerly known as Scratch) is an e-commerce service that helps consumers give great gifts (to someone else or to treat themselves!). Unless you know exactly what you’re looking for, finding a great product online can be a challenge. We believe you shouldn’t have to settle for whatever shows up on the first page of search results, so we’re building a service that makes giving great gifts, from unique brands, as easy as sending a text message. Featured as Apple’s top ‘Best New App’ in February 2016, our chat-based mobile and web app connects customers with a network of gift shoppers, on-demand, from any device. We supercharge our shoppers with the extensive data we’ve accumulated through thousands of customer interactions, which helps us send on-target recommendations quickly, every time. Customers simply tell us who they are shopping for and answer a couple questions about their interests. Within a few hours, our shoppers send them great recommendations from unique brands. It’s completely free and customers can buy right from us with confidence, since every purchase is backed by our best price guarantee. Founded in August 2014, we've raised $3.6M so far from top-tier VCs Bessemer Venture Partners, NextView Ventures, Red Swan and Aspiration Growth. Our team includes alums from TripAdvisor, Microsoft, Wayfair, RunKeeper, CustomMade and Karmaloop.

N Toggle

Series A in 2015
nToggle delivers heightened efficiency and transparency for buyers and sellers amidst the rapid rise of programmatic advertising. nToggle's proprietary algorithm-driven software platform helps supply and demand partners manage the ever expanding bid stream. nToggle's big data platform “toggles” real time bidding requests across all digital media utilizing the latest analytical and machine learning techniques to optimally match supply and demand.

Allena Pharmaceuticals

Series B in 2014
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Fuze

Series C in 2014
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

Quantopian

Series B in 2014
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Intigua

Series B in 2014
Intigua virtualizes the management layer, bringing cloud-grade scalability and agility to infrastructure monitoring and management for the first time. It enables enterprises to ensure the performance, availability, and security of business-critical applications running on large-scale physical, virtual, private and public cloud, and hybrid infrastructures.

Ellevation

Venture Round in 2014
Ellevation, LLC is a Boston-based company that develops a web-based software platform aimed at supporting English learners (EL) and the educators who serve them. The platform organizes EL student data, facilitates critical monitoring processes, and aids in instructional planning for multilingual students. Ellevation offers research-based instructional practices and activities that assist classroom teachers in effectively planning lessons to help ELs acquire language skills and master grade-level content. Additionally, the company provides Ellevation Math, specifically designed to help ELs engage with grade-level math concepts. Serving various public school districts, including EL coordinators, specialists, and teachers, Ellevation aims to enhance educational outcomes for English learners across the United States. Founded in 2006, the company was previously known as ESL Innovations, Inc. and rebranded to Ellevation, LLC in 2011.

Proteon Therapeutics

Series D in 2014
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

CloudLock

Series C in 2014
CloudLock LLC is a cloud cybersecurity company that specializes in providing enterprise-class solutions for organizations to secure their data in public cloud environments. Founded in 2007 and headquartered in Waltham, Massachusetts, with additional offices in San Francisco, Arlington, and Tel Aviv, CloudLock offers a comprehensive platform that includes security for cloud applications and infrastructure. Its services encompass content analysis, policy automation, incident management, security analytics, and user behavior monitoring, enabling organizations to maintain regulatory compliance while protecting their cloud environments. CloudLock serves a diverse range of industries, including manufacturing, technology, finance, healthcare, and education. In 2016, the company became a subsidiary of Cisco Systems, further enhancing its capabilities in cloud data security.

Infinio

Series B in 2013
Infinio addresses the most expensive bottleneck in virtual environments: storage performance. Data center administrators buy more storage hardware when what they really want is better storage performance. Infinio offers a software-only solution instead. Infinio has strong financial backing from tier-one venture capitalists including Highland Capital Partners, Bessemer Venture Partners, Lightspeed Venture Partners and Osage University Partners.

Anaqua

Private Equity Round in 2013
Anaqua offers intellectual property (IP) management software and services tailored for various users, including large IP owners, smaller teams, and law firms. Its product suite includes Anaqua Enterprise for larger organizations, Anaqua Express for smaller teams, ANAQUA Element for cloud-based IP management, and ANAQUA Essential for legal practices. The company's solutions address all aspects of the IP lifecycle, covering inventions, patents, trademarks, and more. Anaqua's platform is entirely web-based, featuring automated workflows, integrated document and email management, and advanced query and reporting capabilities. By enhancing business productivity and improving IP visibility, Anaqua supports all participants in the IP management process.

Fuze

Series B in 2013
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

Ellevation

Series A in 2013
Ellevation, LLC is a Boston-based company that develops a web-based software platform aimed at supporting English learners (EL) and the educators who serve them. The platform organizes EL student data, facilitates critical monitoring processes, and aids in instructional planning for multilingual students. Ellevation offers research-based instructional practices and activities that assist classroom teachers in effectively planning lessons to help ELs acquire language skills and master grade-level content. Additionally, the company provides Ellevation Math, specifically designed to help ELs engage with grade-level math concepts. Serving various public school districts, including EL coordinators, specialists, and teachers, Ellevation aims to enhance educational outcomes for English learners across the United States. Founded in 2006, the company was previously known as ESL Innovations, Inc. and rebranded to Ellevation, LLC in 2011.

Alcresta

Series B in 2013
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

Affirmed Networks

Series C in 2013
Affirmed Networks, Inc. specializes in providing mobile content cloud solutions globally, focusing on virtualization and network functions. Founded in 2010 and based in Acton, Massachusetts, the company offers a range of services including the Affirmed Service Automation Platform, which helps mobile operators streamline service introduction and reduce operational costs. Their solutions encompass a cloud-based virtual network for Internet of Things services, critical data communications for telecommunications, and virtualized Evolved Packet Core solutions for live traffic management. Additionally, Affirmed Networks has developed UnityCloud 5G core, a cloud-native platform designed to facilitate the deployment of 5G networks for mobile operators. The company's innovative approach aims to enhance intelligence and efficiency in mobile data networks.

Infinio

Series A in 2013
Infinio addresses the most expensive bottleneck in virtual environments: storage performance. Data center administrators buy more storage hardware when what they really want is better storage performance. Infinio offers a software-only solution instead. Infinio has strong financial backing from tier-one venture capitalists including Highland Capital Partners, Bessemer Venture Partners, Lightspeed Venture Partners and Osage University Partners.

JetPatch

Series A in 2013
JetPatch is a centralized patch management platform that specializes in end-to-end enterprise patch management and vulnerability remediation. Founded in 2017 and headquartered in Newton Center, Massachusetts, the platform ensures that systems remain secure, up-to-date, and operational through automated patch management. It enhances existing patch management tools and significantly reduces the time IT and DevOps professionals spend on deploying, maintaining, and troubleshooting server tool agents. By utilizing machine learning technology, JetPatch optimizes patch rollouts, leading to improved system security and reduced downtime. The platform is designed to support large-scale physical, virtual, private, public cloud, and hybrid infrastructures, thereby enabling enterprises to maintain the performance and availability of their critical applications.

Cerulean Pharma

Private Equity Round in 2012
Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on developing innovative therapeutics utilizing nanotechnology, particularly in the fields of oncology, cardiovascular, autoimmune, and inflammatory diseases. The company specializes in nanoparticle-drug conjugates, which are designed to specifically target tumors, reduce toxicity, and facilitate drug combinations. Among its product offerings is Ovaprene, a non-hormonal contraceptive that provides extended protection. Cerulean Pharma has assembled a distinguished team, including a management team, board of directors, and scientific advisory board, all of whom possess extensive experience in business development and scientific research from prominent organizations and institutions.

Fuze

Series A in 2012
Fuze is a cloud-based unified communications platform that enhances productivity and collaboration within organizations. It offers tools for simplified voice communications, flexible video conferencing, and continuous collaboration, allowing modern, mobile workforces to communicate seamlessly across various devices. Fuze’s platform aggregates data from multiple sources, providing valuable insights that help business leaders understand and improve their operations and workforce dynamics. Founded in 2002 and originally known as ThinkingPhones, Fuze is headquartered in Boston, Massachusetts, with additional offices in various global cities, including New York, San Francisco, and London. The company serves a diverse clientele, including well-known organizations such as CareerBuilder, Fujitsu, and Oregon Health & Sciences University.

WireOver

Seed Round in 2012
WireOver is a desktop application that leverages peer-to-peer technology for sending files privately. It's free and unlimited, solving an unmet need for sending large files easily. Pro accounts get incredibly strong security, with end-to-end encryption.

InsightSquared

Series A in 2012
InsightSquared, Inc. specializes in sales performance analytics tailored for software as a service (SaaS) businesses. The company provides a comprehensive Revenue Intelligence Platform that includes multiple integrated solutions, enabling organizations to access actionable, real-time intelligence. Key offerings include Tiles, a reporting solution for sales analytics, and Slate, a report builder that consolidates data from various sources to extract insights. Additional services encompass marketing analytics, report authoring, and staffing analytics. InsightSquared's platform is designed to help businesses enhance their sales operations by improving pipeline management, conversion rates, and forecast accuracy, while also facilitating employee performance tracking and strategic decision-making. Founded in 2010 and headquartered in Boston, Massachusetts, InsightSquared also has an office in Austin, Texas. The company was formerly known as ClearInsight, Inc. before rebranding in December 2011.

Alcresta

Series A in 2012
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

Apperian

Series B in 2012
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

Cerulean Pharma

Series D in 2011
Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on developing innovative therapeutics utilizing nanotechnology, particularly in the fields of oncology, cardiovascular, autoimmune, and inflammatory diseases. The company specializes in nanoparticle-drug conjugates, which are designed to specifically target tumors, reduce toxicity, and facilitate drug combinations. Among its product offerings is Ovaprene, a non-hormonal contraceptive that provides extended protection. Cerulean Pharma has assembled a distinguished team, including a management team, board of directors, and scientific advisory board, all of whom possess extensive experience in business development and scientific research from prominent organizations and institutions.

Allena Pharmaceuticals

Series A in 2011
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Verastem

Series C in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Hadapt

Series A in 2011
Hadapt is a developer of an adaptive analytical platform designed to facilitate complex analytics on both structured and unstructured data. This platform operates in private and public cloud environments, providing a cloud-optimized system for data analysis. Hadapt's Adaptive Query Execution solution enhances performance by dynamically load balancing queries in virtualized settings, enabling analytical workloads to be efficiently distributed between relational database engines and Hadoop, an open-source parallel data processing framework. Additionally, the platform supports SQL, making it versatile for various analytical tasks.

Proteon Therapeutics

Series C in 2011
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Verastem

Series B in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Apperian

Venture Round in 2011
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

Tilera

Series D in 2011
Tilera Corporation is a fabless semiconductor company that specializes in designing multicore embedded processors tailored for the networking, digital multimedia, and wireless infrastructure markets. Established in 2004 and headquartered in San Jose, California, with additional locations in Westborough, Massachusetts, and Beijing, China, Tilera provides a range of products including the TILEPro multicore processor, which is engineered to meet the performance demands of embedded applications. The company also offers multicore software development tools and TILExpress PCIe production cards, supporting various processing and power requirements. Tilera's focus on multicore technology enables efficient computing solutions for diverse applications in its targeted industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.